Bempikibart

Q32 Bio presented results from their SIGNAL-AA earlier this month at the American Academy of Dermatology (AAD) 2025 meeting for their novel alopecia areata (AA) therapy bempikibart. What is Bempikibart? Bempikibart is an experimental monoclonal antibody drug that targets two specific molecules in the body: the alpha receptor of interleukin-7 and the thymic stromal lymphopoietin…